Micol Ravà

9PUBLICATIONS
68CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityAgricultural molecular engineering of nucleic acids and proteinsNeural engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 28, 2026
Platelet-derived serotonin drives age-related lung pathology in SARS-CoV-2 infection.

|Jun 30, 2025
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming.

Valentina Venzin, Cristian G Beccaria, Chiara Perucchini

|Mar 15, 2024
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination.

Valeria Fumagalli, Micol Ravà, Davide Marotta

|Oct 28, 2023
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine.

Alberto Grandi, Michele Tomasi, Irfan Ullah

|Jun 09, 2023
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccine.

Alberto Grandi, Michele Tomasi, Irfan Ullah

|Feb 25, 2022
Group 1 ILCs regulate T cell-mediated liver immunopathology by controlling local IL-2 availability.

Valeria Fumagalli, Valentina Venzin, Pietro Di Lucia

Pageof 2

Frequent Collaborators

6 joint publications

Matteo Iannacone

6 joint publications

Valeria Fumagalli

5 joint publications

Luca G Guidotti

4 joint publications

Mirela Kuka